# Purchase Order #75N98026P01815

Purchase Order for Karyotyping Induced Pluripotent Stem Cells to WiCell Research Institute

**Buyer:** National Institutes of Health

**Award Amount:** $49,115.00
**Ceiling:** $49,115.00

**Awarded:** September 23, 2026
**Period of Performance:** Sep 23, 2026 - Dec 31, 2026

**Identifier:** 75N98026P01815
**NAICS:** 541990

This award represents a definitive purchase order contract granted to WiCell Research Institute, Inc., a leading entity specializing in stem cell research and cellular biology. The contract involves karyotyping services of induced pluripotent stem cell (iPSC) lines that exhibit varying sex chromosome dosage, crucial for understanding genetic variations and cellular behavior. The work supports scientific and medical research initiatives by providing detailed chromosomal analysis data, which is significant for advancing regenerative medicine and therapeutic developments. The contract covers the performance of detailed laboratory analyses and reporting of results within a defined period. The procurement was awarded through a competitive process, reflecting the recipient's specialized capability. The contract has a short-term timeline, commencing and concluding within a few months during 2026, and the performance location is Madison, Wisconsin.

### Description

KARYOTYPING OF INDUCED PLURIPOTENT STEM CELLS (IPSC) LINES WITH VARYING SEX CHROMOSOME DOSAGE

[View original record](https://www.usaspending.gov/award/CONT_AWD_75N98026P01815_7529_-NONE-_-NONE-)